Phibro Animal Health Corporation (NASDAQ:PAHC) Shareholders to Receive $0.12 Quarterly Dividend

Key Points

• Phibro Animal Health declared a $0.12 quarterly dividend, payable December 16 to shareholders of record November 25. The annualized dividend is $0.48 per share, a 1.3% yield.
• The dividend appears well covered: the current payout ratio is 23.9%, and analysts expect it to fall to 12.6% based on forecast earnings.
• In its latest reported quarter, Phibro earned $0.85 per share and generated $396.75 million in revenue, beating analyst estimates for both.

Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report) announced a quarterly dividend on Tuesday, November 3rd. Stockholders of record on Wednesday, November 25th will be given a dividend of $0.12 per share on Wednesday, December 16th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date is Wednesday, November 25th.

Phibro Animal Health has a payout ratio of 23.9% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Phibro Animal Health to earn $3.81 per share next year, which means the company should continue to be able to cover its $0.48 annual dividend with an expected future payout ratio of 12.6%.

Phibro Animal Health Stock Down 2.8%

Shares of PAHC stock opened at $37.65 on Wednesday. Phibro Animal Health has a 1-year low of $28.25 and a 1-year high of $60.08. The stock's fifty day moving average price is $37.09 and its 200 day moving average price is $41.10. The company has a debt-to-equity ratio of 1.84, a current ratio of 2.96 and a quick ratio of 1.27. The company has a market cap of $1.53 billion, a price-to-earnings ratio of 15.43 and a beta of 0.42.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its earnings results on Wednesday, August 26th. The company reported $0.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.14. The company had revenue of $396.75 million for the quarter, compared to analyst estimates of $381.18 million. Phibro Animal Health had a return on equity of 37.86% and a net margin of 6.57%. Phibro Animal Health has set its FY 2027 guidance at 3.410-3.590 EPS. On average, research analysts expect that Phibro Animal Health will post 3.49 earnings per share for the current fiscal year.

About Phibro Animal Health

Phibro Animal Health Corporation develops, manufactures and sells products designed to support the health, nutrition and productivity of food-producing animals. Its offerings include animal health products, vaccines, medicated feed additives, nutritional specialties and performance products used in livestock, poultry and aquaculture.

The company's products are intended to help prevent and manage disease, improve animal well-being and support efficient food production. Phibro serves producers, veterinarians, feed manufacturers and distributors through a portfolio that includes pharmaceuticals, vaccines, mineral and nutritional supplements, and other feed and water solutions.

Phibro Animal Health markets its products internationally across a broad range of geographic regions, including North America, Latin America, Europe, Asia-Pacific and other global markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.